BrightEdge is the innovation and impact investment arm of the American Cancer Society, based in Kennesaw, Georgia. Through its donor-funded ACS Impact Venture Fund (AIVF), it invests in for-profit, early-stage companies developing cancer-focused therapeutics, diagnostics, devices, and enabling technologies, evaluating opportunities against its own Cancer Impact Investment Framework (CIIF), which w...
London, United Kingdom
Pasadena, United States
San Francisco, United States
London, United Kingdom
Toronto, Canada
London, United Kingdom